CRTonline Podcast
Kanavan tiedot
CRTonline Podcast
CRTonline Podcast is a collection of interviews with well renowned physicians on medical journals and on-going issues around the world of medicine.
Viimeisimmät jaksot
362 jaksoa
Immediate Instantaneous Wave-Free Ratio Guided Versus Deferred Cardiac Magnetic Resonance Imaging Guided Revascularization of Non-Culprit Lesions
Immediate Instantaneous Wave-Free Ratio Guided Versus Deferred Cardiac Magnetic Resonance Imaging Guided Revascularization of Non-Culprit Lesions
STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus
STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus
PROCTOR: A Multicenter, Open-label, Randomized Trial
PROCTOR: A Multicenter, Open-label, Randomized Trial
3-Year Clinical Outcomes of the REC-CAGEFREE I Trial
3-Year Clinical Outcomes of the REC-CAGEFREE I Trial
Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study
Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study
Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial
Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial
Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
Results from STORM-PE - Randomized Controlled Trial
Results from STORM-PE - Randomized Controlled Trial
The VICTORY Trial - A Randomized, Multicenter, Non-Inferiority Comparison
The VICTORY Trial - A Randomized, Multicenter, Non-Inferiority Comparison
Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis
Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis
King and I | S6 E4 | Who Needs MCS for High-Risk PCI
King and I | S6 E4 | Who Needs MCS for High-Risk PCI
Impact of Cerebral Embolic Protection on Cognition: Experience from BHF PROTECT-TAVI
Impact of Cerebral Embolic Protection on Cognition: Experience from BHF PROTECT-TAVI
OPTION-STEMI: Timing of Complete Revascularization During Index Hospitalization in Patients with STEMI and Multivessel Disease
OPTION-STEMI: Timing of Complete Revascularization During Index Hospitalization in Patients with STEMI and Multivessel Disease
IPD Meta-Analysis of Contemporary Trials Comparing TAVI versus SAVR
IPD Meta-Analysis of Contemporary Trials Comparing TAVI versus SAVR
TACSI: Dual or Single Antiplatelet Therapy After CABG in ACS Patients
TACSI: Dual or Single Antiplatelet Therapy After CABG in ACS Patients
DAPT-SHOCK-AMI Trial: Cangrelor in Cardiogenic Shock
DAPT-SHOCK-AMI Trial: Cangrelor in Cardiogenic Shock
TARGET-FIRST: Early Aspirin Discontinuation After PCI in Acute MI Patients
TARGET-FIRST: Early Aspirin Discontinuation After PCI in Acute MI Patients
TAILORED-CHIP: Tailored Antiplatelet Therapy for Complex High-Risk PCI
TAILORED-CHIP: Tailored Antiplatelet Therapy for Complex High-Risk PCI
NEO-MINDSET: Early Withdrawal of Aspirin After PCI for ACS
NEO-MINDSET: Early Withdrawal of Aspirin After PCI for ACS
DOUBLE-CHOICE: Anesthesia strategies and self-expanding valve types for TAVI
DOUBLE-CHOICE: Anesthesia strategies and self-expanding valve types for TAVI
King and I | S6 E3 | Should EKG be the Discriminator for STEMI
King and I | S6 E3 | Should EKG be the Discriminator for STEMI
The Impact of Gender on Outcomes of Transcatheter Aortic Valve Implantation Between Self-Expanding Valve and Balloon-Expandable Valve
The Impact of Gender on Outcomes of Transcatheter Aortic Valve Implantation Between Self-Expanding Valve and Balloon-Expandable Valve
Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years
Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years
Is the axiom of balloon angioplasty, “the more you gain the more you lose,” still true in the era of DCB with paclitaxel?
Is the axiom of balloon angioplasty, “the more you gain the more you lose,” still true in the era of DCB with paclitaxel?
Examining patient demographics and major adverse cardiac events following noncardiac surgery: Applying a health equity lens
Examining patient demographics and major adverse cardiac events following noncardiac surgery: Applying a health equity lens
Angiographic and clinical impact of balloon inflation time in percutaneous coronary interventions with sirolimus-coated balloon: A sub analysis of the EASTBOURNE study
Angiographic and clinical impact of balloon inflation time in percutaneous coronary interventions with sirolimus-coated balloon: A sub analysis of the...
Findings from EuroPCR 2025—What You Need to Know
Findings from EuroPCR 2025—What You Need to Know
EuroIntervention Highlights and Key Trial Recap from EuroPCR
EuroIntervention Highlights and Key Trial Recap from EuroPCR
King and I | S6 E2 | Welcome IC Fellows of 2025: Things You Need to Know
King and I | S6 E2 | Welcome IC Fellows of 2025: Things You Need to Know